No pain, no gain? The effects of pain-promoting neuropeptides and neurotrophins on fracture healing

Seungyup Sun, Nicklaus H. Diggins, Zachary J. Gunderson, Jill C. Fehrenbacher, Fletcher A. White, Melissa A. Kacena

Research output: Contribution to journalReview article

Abstract

Neuropeptides and neurotrophins are key regulators of peripheral nociceptive nerves and contribute to the induction, sensitization, and maintenance of pain. It is now known that these peptides also regulate non-neuronal tissues, including bone. Here, we review the effects of numerous neuropeptides and neurotrophins on fracture healing. The neuropeptides calcitonin-gene related peptide (CGRP), substance P (SP), vasoactive intestinal peptide (VIP), and pituitary adenylate cyclase-activating peptide (PACAP) have varying effects on osteoclastic and osteoblastic activity. Ultimately, CGRP and SP both accelerate fracture healing, while VIP and PACAP seem to negatively impact healing. Unlike the aforementioned neuropeptides, the neurotrophins nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) have more uniform effects. Both factors upregulate osteoblastic activity, osteoclastic activity, and, in vivo, stimulate osteogenesis to promote fracture healing. Future research will need to clarify the exact mechanism by which the neuropeptides and neurotrophins influence fracture healing. Specifically, understanding the optimal expression patterns for these proteins in the fracture healing process may lead to therapies that can maximize their bone-healing capabilities and minimize their pain-promoting effects. Finally, further examination of protein-sequestering antibodies and/or small molecule agonists and antagonists may lead to new therapies that can decrease the rate of delayed union/nonunion outcomes and fracture-associated pain.

Original languageEnglish (US)
Article number115109
JournalBone
Volume131
DOIs
StatePublished - Feb 2020

Fingerprint

Fracture Healing
Nerve Growth Factors
Neuropeptides
Pain
Calcitonin Gene-Related Peptide
Vasoactive Intestinal Peptide
Substance P
Adenylyl Cyclases
Peptides
Bone and Bones
Brain-Derived Neurotrophic Factor
Nerve Growth Factor
Peripheral Nerves
Osteogenesis
Proteins
Up-Regulation
Maintenance
Antibodies
Therapeutics

Keywords

  • Bone regeneration
  • Fracture healing
  • Musculoskeletal pain
  • Nerve growth factors
  • Neuropeptides
  • Nociceptors

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Physiology
  • Histology

Cite this

No pain, no gain? The effects of pain-promoting neuropeptides and neurotrophins on fracture healing. / Sun, Seungyup; Diggins, Nicklaus H.; Gunderson, Zachary J.; Fehrenbacher, Jill C.; White, Fletcher A.; Kacena, Melissa A.

In: Bone, Vol. 131, 115109, 02.2020.

Research output: Contribution to journalReview article

Sun, Seungyup ; Diggins, Nicklaus H. ; Gunderson, Zachary J. ; Fehrenbacher, Jill C. ; White, Fletcher A. ; Kacena, Melissa A. / No pain, no gain? The effects of pain-promoting neuropeptides and neurotrophins on fracture healing. In: Bone. 2020 ; Vol. 131.
@article{51a155b8b8e54f4a80ee46c616d74d8c,
title = "No pain, no gain? The effects of pain-promoting neuropeptides and neurotrophins on fracture healing",
abstract = "Neuropeptides and neurotrophins are key regulators of peripheral nociceptive nerves and contribute to the induction, sensitization, and maintenance of pain. It is now known that these peptides also regulate non-neuronal tissues, including bone. Here, we review the effects of numerous neuropeptides and neurotrophins on fracture healing. The neuropeptides calcitonin-gene related peptide (CGRP), substance P (SP), vasoactive intestinal peptide (VIP), and pituitary adenylate cyclase-activating peptide (PACAP) have varying effects on osteoclastic and osteoblastic activity. Ultimately, CGRP and SP both accelerate fracture healing, while VIP and PACAP seem to negatively impact healing. Unlike the aforementioned neuropeptides, the neurotrophins nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) have more uniform effects. Both factors upregulate osteoblastic activity, osteoclastic activity, and, in vivo, stimulate osteogenesis to promote fracture healing. Future research will need to clarify the exact mechanism by which the neuropeptides and neurotrophins influence fracture healing. Specifically, understanding the optimal expression patterns for these proteins in the fracture healing process may lead to therapies that can maximize their bone-healing capabilities and minimize their pain-promoting effects. Finally, further examination of protein-sequestering antibodies and/or small molecule agonists and antagonists may lead to new therapies that can decrease the rate of delayed union/nonunion outcomes and fracture-associated pain.",
keywords = "Bone regeneration, Fracture healing, Musculoskeletal pain, Nerve growth factors, Neuropeptides, Nociceptors",
author = "Seungyup Sun and Diggins, {Nicklaus H.} and Gunderson, {Zachary J.} and Fehrenbacher, {Jill C.} and White, {Fletcher A.} and Kacena, {Melissa A.}",
year = "2020",
month = "2",
doi = "10.1016/j.bone.2019.115109",
language = "English (US)",
volume = "131",
journal = "Bone",
issn = "8756-3282",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - No pain, no gain? The effects of pain-promoting neuropeptides and neurotrophins on fracture healing

AU - Sun, Seungyup

AU - Diggins, Nicklaus H.

AU - Gunderson, Zachary J.

AU - Fehrenbacher, Jill C.

AU - White, Fletcher A.

AU - Kacena, Melissa A.

PY - 2020/2

Y1 - 2020/2

N2 - Neuropeptides and neurotrophins are key regulators of peripheral nociceptive nerves and contribute to the induction, sensitization, and maintenance of pain. It is now known that these peptides also regulate non-neuronal tissues, including bone. Here, we review the effects of numerous neuropeptides and neurotrophins on fracture healing. The neuropeptides calcitonin-gene related peptide (CGRP), substance P (SP), vasoactive intestinal peptide (VIP), and pituitary adenylate cyclase-activating peptide (PACAP) have varying effects on osteoclastic and osteoblastic activity. Ultimately, CGRP and SP both accelerate fracture healing, while VIP and PACAP seem to negatively impact healing. Unlike the aforementioned neuropeptides, the neurotrophins nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) have more uniform effects. Both factors upregulate osteoblastic activity, osteoclastic activity, and, in vivo, stimulate osteogenesis to promote fracture healing. Future research will need to clarify the exact mechanism by which the neuropeptides and neurotrophins influence fracture healing. Specifically, understanding the optimal expression patterns for these proteins in the fracture healing process may lead to therapies that can maximize their bone-healing capabilities and minimize their pain-promoting effects. Finally, further examination of protein-sequestering antibodies and/or small molecule agonists and antagonists may lead to new therapies that can decrease the rate of delayed union/nonunion outcomes and fracture-associated pain.

AB - Neuropeptides and neurotrophins are key regulators of peripheral nociceptive nerves and contribute to the induction, sensitization, and maintenance of pain. It is now known that these peptides also regulate non-neuronal tissues, including bone. Here, we review the effects of numerous neuropeptides and neurotrophins on fracture healing. The neuropeptides calcitonin-gene related peptide (CGRP), substance P (SP), vasoactive intestinal peptide (VIP), and pituitary adenylate cyclase-activating peptide (PACAP) have varying effects on osteoclastic and osteoblastic activity. Ultimately, CGRP and SP both accelerate fracture healing, while VIP and PACAP seem to negatively impact healing. Unlike the aforementioned neuropeptides, the neurotrophins nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) have more uniform effects. Both factors upregulate osteoblastic activity, osteoclastic activity, and, in vivo, stimulate osteogenesis to promote fracture healing. Future research will need to clarify the exact mechanism by which the neuropeptides and neurotrophins influence fracture healing. Specifically, understanding the optimal expression patterns for these proteins in the fracture healing process may lead to therapies that can maximize their bone-healing capabilities and minimize their pain-promoting effects. Finally, further examination of protein-sequestering antibodies and/or small molecule agonists and antagonists may lead to new therapies that can decrease the rate of delayed union/nonunion outcomes and fracture-associated pain.

KW - Bone regeneration

KW - Fracture healing

KW - Musculoskeletal pain

KW - Nerve growth factors

KW - Neuropeptides

KW - Nociceptors

UR - http://www.scopus.com/inward/record.url?scp=85074931151&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85074931151&partnerID=8YFLogxK

U2 - 10.1016/j.bone.2019.115109

DO - 10.1016/j.bone.2019.115109

M3 - Review article

C2 - 31715336

AN - SCOPUS:85074931151

VL - 131

JO - Bone

JF - Bone

SN - 8756-3282

M1 - 115109

ER -